139. Congenital cerebral hypomyelination Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 7 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 2
Congenital cerebral hypomyelination and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 139 | Congenital cerebral hypomyelination |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 19 | Lysosomal storage disease |
| 49 | Systemic lupus erythematosus |
| 222 | Primary nephrotic syndrome |
| 78 | Hypopituitarism |
| 210 | Single Ventricle |
| 80 | Resistance to thyroid hormone |
| 212 | Tricuspid atresia |